Stockreport

AVEO down 4% on mid-stage tivozanib data in kidney cancer [Seeking Alpha]

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF AVEO Oncology ( AVEO ) is down out of the gate this morning following the presentation of Phase 1b/2 data at ESMO on FOTIVDA (tivozanib), combined with Bristo [Read more]